PBI
69
4
VRSN
53
-4
EMN
60
4
ADBE
49
3
BMY
60
2
PSA
58
2
AMG
54
2
CL
58
2
CINF
53
2
ACN
52
3
DRI
53
5
LMT
34
2
HCP
66
8
BK
74
2
WU
32
2
AN
58
4
PAYX
53
2
GOOGL
40
-5
STI
14
-17
KLAC
47
4
PBI
69
4
VRSN
53
-4
EMN
60
4
ADBE
49
3
BMY
60
2
PSA
58
2
AMG
54
2
CL
58
2
CINF
53
2
ACN
52
3
DRI
53
5
LMT
34
2
HCP
66
8
BK
74
2
WU
32
2
AN
58
4
PAYX
53
2
GOOGL
40
-5
STI
14
-17
KLAC
47
4
Financhill
Back

Avenue Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
17

ATXI
Avenue Therapeutics

Last Price:
2.08
Seasonality Move:
0.6%
Sell
28

NBY
NovaBay Pharmaceuticals

Last Price:
0.62
Seasonality Move:
1.46%
Sell
17
Avenue Therapeutics (ATXI) is a Sell

Is Avenue Therapeutics a Buy, Sell or Hold?

  • The current Avenue Therapeutics [ATXI] share price is $2.01. The Score for ATXI is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • ATXI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
28
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.68. The Score for NBY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ATXI Stock Price Chart

What is Avenue Therapeutics's stock price today?

  • The Avenue Therapeutics share price today is $2.01
    The current trend is relatively stagnant and ATXI is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.

ATXI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 44.01 Sell
Chaikin Money Flow: -36506 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.95 - 2.31) Sell
Bollinger Bands (100): (2.1 - 3.06) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 48.48 Sell
Chaikin Money Flow: -30586 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.75) Buy
Bollinger Bands (100): (0.28 - 1.42) Sell

ATXI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.96 Buy
20-day SMA: 2.14 Sell
50-day SMA: 2.23 Sell
200-day SMA: 5.19 Sell
8-day EMA: 2 Buy
20-day EMA: 2.08 Sell
50-day EMA: 2.27 Sell
200-day EMA: 12.35 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.71 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.66 Buy
200-day SMA: 2.33 Sell
8-day EMA: 0.71 Sell
20-day EMA: 0.7 Sell
50-day EMA: 0.73 Sell
200-day EMA: 5.57 Sell

Avenue Therapeutics Earnings Growth & ATXI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Avenue Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):